Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Technical Analysis

Compare
612 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.60, suggesting Genmab A/S is a Buy.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 19.87, while Genmab A/S’s (GMAB) share price is $18.39, making it a Sell.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 20.58, while Genmab A/S’s (GMAB) share price is $18.39, making it a Sell.

Genmab (GMAB) Pivot Points

Apr 06, 2025, 06:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.10
19.23
19.40
19.53
19.71
19.84
20.01
Fibonacci
19.23
19.34
19.42
19.53
19.65
19.72
19.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

Apr 06, 2025, 06:06 PM
Period
Simple
Exponential
MA5
18.94Sell
18.94Sell
MA10
19.27Sell
19.29Sell
MA20
19.82Sell
19.87Sell
MA50
20.66Sell
20.58Sell
MA100
20.93Sell
21.37Sell
MA200
23.28Sell
23.45Sell
Genmab A/S’s (GMAB) 10-Day exponential moving average is 19.29, while Genmab A/S’s (GMAB) share price is $18.39, making it a Sell.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 21.37, while Genmab A/S’s (GMAB) share price is $18.39, making it a Sell.
Genmab A/S’s (GMAB) stock price is $18.39 and Genmab A/S’s (GMAB) 50-day simple moving average is 20.66, creating a Sell signal.
Genmab A/S’s (GMAB) stock price is $18.39 and Genmab A/S’s (GMAB) 100-day simple moving average is 20.93, creating a Sell signal.
Genmab A/S’s (GMAB) stock price is $18.39 and Genmab A/S’s (GMAB) 200-day simple moving average is 23.28, creating a Sell signal.

Genmab (GMAB) Technical Indicators

Apr 06, 2025, 06:06 PM
Name
Value
Implied Action
RSI (14)
35.10
Neutral
STOCH (9,6)
33.93
Neutral
STOCHRSI (14)
24.56
Neutral
MACD (12,26)
-0.60
Buy
ADX (14)
22.59
Neutral
Williams %R
-98.45
Buy
CCI (14)
-103.78
Buy
ATR (14)
0.68
-
Ultimate Oscillator
39.76
Neutral
ROC
-11.59
Sell
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 35.10, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 22.59, creating a Neutral signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is -103.78, creating a Buy signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is -11.59, creating a Sell signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Strong Sell.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 35.10, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is -0.60, which suggests GMAB is a Buy.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 18.94, which suggests GMAB is a Sell.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 19.82, which suggests GMAB is a Sell.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 20.66, which suggests GMAB is a Sell.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 23.28, which suggests GMAB is a Sell.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -98.45, which suggests GMAB is a Buy.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is -103.78, which suggests GMAB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis